Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
NRG Oncology
Pfizer
mAbxience Research S.L.
NRG Oncology
Idera Pharmaceuticals, Inc.
Delcath Systems Inc.
Pfizer
Celgene
Alliance for Clinical Trials in Oncology
Eli Lilly and Company
AstraZeneca
AVAX Technologies
National Cancer Institute (NCI)
Vical
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Bristol-Myers Squibb
University Hospital, Bordeaux
University of Wuerzburg